Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Manuela Kempkes-Koch"'
Autor:
Götz Ehlerding, Wolfgang Ries, Manuela Kempkes-Koch, Ekkehard Ziegler, Petra Ronová, Mária Krizsán, Jana Verešová, Mária Böke, Ansgar Erlenkötter, Robert Nitschel, Adam M. Zawada, James P. Kennedy, Jennifer Braun, John W. Larkin, Natalia Korolev, Thomas Lang, Bertram Ottillinger, Manuela Stauss-Grabo, Bettina Griesshaber
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Hemodialyzers should efficiently eliminate small and middle molecular uremic toxins and possess exceptional hemocompatibility to improve well-being of patients with end-stage kidney disease. However, performance and hemocompatibil
Externí odkaz:
https://doaj.org/article/4b66a40a5a4e402184c83ded7f823087
Autor:
Ekkehard Ziegler, Ansgar Erlenkötter, Bertram Ottillinger, Wolfgang Ries, Adam M Zawada, Manuela Kempkes-Koch, Thomas Lang, Götz Ehlerding, Manuela Stauss-Grabo, James Kennedy
Publikováno v:
Clinical kidney journal. 15(4)
Background Dialyzers should be designed to efficiently eliminate uraemic toxins during dialysis treatment, given that the accumulation of small and middle molecular weight uraemic solutes is associated with increased mortality risk of patients with e
Autor:
James Kennedy, Adelheid Gauly, Hans Schmidt-Gürtler, Lena Rauber, Manuela Kempkes-Koch, Ansgar Erlenkötter, Manuela Stauss-Grabo
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Hemodialyzers containing membranes made from a blend of polysulfone and polyvinylpyrrolidone (PVP) are widely used. PVP makes the membrane material more hydrophilic to reduce interactions with plasma proteins and platelets. A modi
Autor:
Lena Rauber, Sebastian Zschätzsch, Stephan Wagner, Manuela Kempkes-Koch, Ansgar Erlenkötter, Adelheid Gauly, Manuela Stauss-Grabo, Götz Ehlerding, Adam M Zawada, Wolfgang Ries, James Kennedy, Hans Schmidt-Gürtler, Bettina Griesshaber
Publikováno v:
Kidney360
BACKGROUND: High-flux dialyzers effectively remove uremic toxins, are hemocompatible to minimize intradialytic humoral and cellular stimulation, and have long-term effects on patient outcomes. A new dialyzer with a modified membrane surface has been